A1cChek Pro Glycohemoglobin Analyzer
Diabetes monitoring (HbA1c)
CommercialFDA 510(k) cleared, CLIA waiver submitted
Key Facts
Indication
Diabetes monitoring (HbA1c)
Phase
Commercial
Status
FDA 510(k) cleared, CLIA waiver submitted
About BioHermes Bio & Medical Technology
Chinese diagnostics company focused on point-of-care HbA1c analyzers for diabetes management, with FDA-cleared products and global market presence.
View full company profileTherapeutic Areas
Other Diabetes monitoring (HbA1c) Drugs
| Drug | Company | Phase |
|---|---|---|
| BH60 Automated Glycohemoglobin Analyzer | BioHermes Bio & Medical Technology | Commercial |